Education
About Us
Working with TipRanks
Follow Us
Glenmark Pharmaceuticals Limited (IN:GLENMARK)
:GLENMARK
| Mar 24 | Mar 23 | Mar 22 | Mar 21 | Mar 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ₹ 118.13B | ₹ 127.25B | ₹ 121.74B | ₹ 108.06B | ₹ 103.97B |
| Gross Profit | ₹ 32.59B | ₹ 81.88B | ₹ 77.14B | ₹ 70.62B | ₹ 66.31B |
| Operating Income | ₹ 6.50B | ₹ 16.67B | ₹ 18.40B | ₹ 17.16B | ₹ 12.98B |
| EBITDA | ₹ 11.34B | ₹ 11.58B | ₹ 22.26B | ₹ 21.79B | ₹ 18.91B |
| Net Income | ₹ -15.02B | ₹ 2.97B | ₹ 9.42B | ₹ 9.70B | ₹ 7.76B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ₹ 16.64B | ₹ 16.44B | ₹ 14.43B | ₹ 12.14B | ₹ 11.80B |
| Total Assets | ₹ 143.59B | ₹ 193.72B | ₹ 170.83B | ₹ 156.04B | ₹ 146.85B |
| Total Debt | ₹ 12.31B | ₹ 46.27B | ₹ 39.62B | ₹ 49.86B | ₹ 51.86B |
| Net Debt | ₹ -4.27B | ₹ 31.84B | ₹ 25.51B | ₹ 38.48B | ₹ 40.76B |
| Total Liabilities | ₹ 65.11B | ₹ 95.32B | ₹ 76.45B | ₹ 85.39B | ₹ 86.15B |
| Stockholders' Equity | ₹ 78.48B | ₹ 94.74B | ₹ 90.87B | ₹ 70.65B | ₹ 60.71B |
| Cash Flow | |||||
| Free Cash Flow | ₹ -11.64B | ₹ 176.29M | ₹ 3.19B | ₹ 3.56B | ₹ 4.61B |
| Operating Cash Flow | ₹ -2.65B | ₹ 6.25B | ₹ 11.09B | ₹ 11.31B | ₹ 13.92B |
| Investing Cash Flow | ₹ 45.44B | ₹ -5.28B | ₹ -3.33B | ₹ -6.75B | ₹ -7.84B |
| Financing Cash Flow | ₹ -39.06B | ₹ -774.56M | ₹ -5.20B | ₹ -4.42B | ₹ -4.45B |